Illumina weakness ‘overdone,’ says Wolfe Research
Wolfe Research reiterated an Outperform rating and $150 price target on Illumina (ILMN) after Roche (RHHBY) presented scientific details about ...
Financial Planning5h
Robinhood faces FINRA questions over its media arm
The popular online broker-dealer has caught regulators' eyes over its moves into market news, trading in sports games and ...